搜尋





搜尋





市場行情
/
股票
/
btai
/

BioXcel Therapeutics Inc

BTAI

添加自選

0.808USD

+0.015+1.92%

收盤 07-31 16:00（美東）報價延遲15分鐘

24.95M總市值

虧損本益比TTM

BioXcel Therapeutics Inc

0.808

+0.015+1.92%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

BTAI 利潤表

您可以在這裡找到BioXcel Therapeutics Inc的年度或季度收入報告，以深入了解BioXcel Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q1

FY2016Q4

FY2016Q3

營業總收入

22.62%206.00K

-30.05%256.00K

-54.21%98.00K

-89.13%120.00K

-71.13%168.00K

-2.66%366.00K

-37.24%214.00K

141.58%1.10M

182.52%582.00K

57.98%376.00K

148.91%341.00K

--457.00K

--206.00K

--238.00K

--137.00K

----

--0.00

營業收入

22.62%206.00K

-30.05%256.00K

-54.21%98.00K

-89.13%120.00K

-71.13%168.00K

-2.66%366.00K

-37.24%214.00K

141.58%1.10M

182.52%582.00K

57.98%376.00K

148.91%341.00K

--457.00K

--206.00K

--238.00K

--137.00K

----

--0.00

主營業務成本

1921.43%283.00K

-96.15%32.00K

-99.06%11.00K

72.58%107.00K

-82.50%14.00K

16.53%832.00K

128.52%1.17M

138.46%62.00K

788.89%80.00K

7833.33%714.00K

4554.55%512.00K

--26.00K

--9.00K

--11.00K

----

營業費用

1.58%10.43M

-2.67%10.54M

1.28%14.13M

-8.96%15.97M

-58.51%10.27M

-46.54%10.83M

-68.63%13.95M

-66.82%17.54M

-51.86%24.75M

-61.89%20.25M

13.67%44.48M

45.70%52.87M

63.29%51.40M

103.33%53.13M

45.93%39.13M

31.42%36.29M

19.34%31.48M

23.86%26.13M

8.25%26.81M

28.82%27.61M

75.91%26.38M

150.77%21.10M

171.16%24.77M

148.23%21.43M

102.13%15.00M

15.04%8.41M

78.43%9.13M

166.18%8.63M

73.10%7.42M

189.51%7.31M

458.23%5.12M

--3.24M

710.21%4.29M

350.27%2.53M

69.19%917.00K

--529.00K

--561.00K

--542.00K

研發費用

-35.11%2.96M

13.56%6.70M

71.34%8.74M

27.69%10.26M

-60.06%4.55M

-40.60%5.90M

-74.00%5.10M

-70.22%8.03M

-58.99%11.40M

-69.40%9.93M

-11.07%19.62M

50.64%26.97M

49.79%27.80M

159.15%32.46M

84.88%22.06M

32.55%17.91M

25.90%18.56M

9.87%12.53M

-26.87%11.93M

-24.56%13.51M

19.16%14.74M

75.52%11.40M

129.11%16.32M

175.22%17.91M

118.03%12.37M

7.93%6.50M

86.39%7.12M

265.30%6.51M

93.12%5.67M

322.02%6.02M

517.29%3.82M

--1.78M

815.26%2.94M

303.97%1.43M

56.31%619.00K

--321.00K

--353.00K

--396.00K

折舊攤銷及損耗

-23.68%58.00K

-3.90%74.00K

-2.60%75.00K

-2.56%76.00K

-1.28%77.00K

-2.53%77.00K

-4.94%77.00K

-2.50%78.00K

-3.70%78.00K

-7.06%79.00K

-3.57%81.00K

3.90%80.00K

6.58%81.00K

10.39%85.00K

5.00%84.00K

18.46%77.00K

68.89%76.00K

60.42%77.00K

66.67%80.00K

38.30%65.00K

--45.00K

-50.00%48.00K

-43.53%48.00K

27.03%47.00K

----

1271.43%96.00K

4150.00%85.00K

--37.00K

--8.00K

600.00%7.00K

--2.00K

-100.00%0.00

--0.00

--1.00K

----

其他營業費用

----

---5.00K

----

營業利潤

-1.23%-10.22M

1.71%-10.28M

-2.14%-14.03M

3.58%-15.85M

58.20%-10.10M

47.37%-10.46M

68.87%-13.74M

68.63%-16.44M

52.80%-24.16M

62.42%-19.88M

-13.19%-44.13M

-44.44%-52.41M

-62.64%-51.20M

-102.42%-52.89M

-45.42%-38.99M

-31.42%-36.29M

-19.34%-31.48M

-23.86%-26.13M

-8.25%-26.81M

-28.82%-27.61M

-75.91%-26.38M

-150.77%-21.10M

-171.16%-24.77M

-148.23%-21.43M

-102.13%-15.00M

-15.04%-8.41M

-78.43%-9.13M

-166.18%-8.63M

-73.10%-7.42M

-189.51%-7.31M

-458.23%-5.12M

---3.24M

-710.21%-4.29M

-350.27%-2.53M

-69.19%-917.00K

---529.00K

---561.00K

---542.00K

淨非營業利息收入（費用）

利息收入

-24.37%211.00K

-12.77%321.00K

-61.69%236.00K

-65.72%230.00K

-70.54%279.00K

-61.10%368.00K

-42.32%616.00K

-58.61%671.00K

-53.00%947.00K

-62.58%946.00K

--1.07M

694.61%1.62M

13333.33%2.02M

20966.67%2.53M

----

1940.00%204.00K

50.00%15.00K

-20.00%12.00K

-40.00%12.00K

-37.50%10.00K

-88.24%10.00K

-89.13%15.00K

-82.76%20.00K

-90.24%16.00K

-60.47%85.00K

-42.02%138.00K

-50.00%116.00K

-24.77%164.00K

5275.00%215.00K

--238.00K

--232.00K

--218.00K

--4.00K

----

利息費用

5.13%4.20M

9.03%4.40M

15.38%4.37M

14.11%4.22M

10.70%3.99M

17.38%4.03M

16.54%3.79M

13.53%3.70M

7.13%3.61M

-13.30%3.44M

13.03%3.25M

105.49%3.26M

48000.00%3.37M

65933.33%3.96M

26054.55%2.88M

9812.50%1.59M

0.00%7.00K

50.00%6.00K

120.00%11.00K

--16.00K

--7.00K

--4.00K

--5.00K

----

--2.00K

----

特殊收入（費用）

----

100.00%0.00

87.51%-194.00K

100.00%0.00

----

---32.00K

62.70%-1.55M

---856.00K

----

--0.00

---4.16M

----

其他非經營性收入（費用）

-76.84%1.52M

-45.06%1.81M

-360.45%-12.55M

-94.54%657.00K

20396.88%6.56M

2953.70%3.30M

96440.00%4.82M

2139.48%12.03M

113.01%32.00K

122.50%108.00K

-108.06%-5.00K

--537.00K

---246.00K

---480.00K

--62.00K

----

稅前利潤

-74.95%-12.69M

-15.53%-12.54M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

51.21%-10.86M

72.96%-13.65M

84.49%-8.30M

49.26%-26.79M

59.39%-22.26M

-20.77%-50.49M

-42.06%-53.52M

-67.76%-52.80M

-109.79%-54.81M

-55.92%-41.80M

-36.39%-37.67M

-19.32%-31.47M

-23.90%-26.13M

-8.31%-26.81M

-28.95%-27.62M

-76.89%-26.38M

-154.82%-21.09M

-174.48%-24.75M

-152.85%-21.42M

-106.98%-14.91M

-16.96%-8.28M

-84.53%-9.02M

-179.94%-8.47M

-68.24%-7.20M

-179.87%-7.08M

-432.93%-4.89M

---3.03M

-709.45%-4.28M

-350.62%-2.53M

-69.19%-917.00K

---529.00K

---561.00K

---542.00K

所得稅

----

--0.00

----

--0.00

----

--0.00

----

--0.00

除稅後利潤

-74.95%-12.69M

-15.53%-12.54M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

51.21%-10.86M

72.96%-13.65M

84.49%-8.30M

49.26%-26.79M

59.39%-22.26M

-20.77%-50.49M

-42.06%-53.52M

-67.76%-52.80M

-109.79%-54.81M

-55.92%-41.80M

-36.39%-37.67M

-19.32%-31.47M

-23.90%-26.13M

-8.31%-26.81M

-28.95%-27.62M

-76.89%-26.38M

-154.82%-21.09M

-174.48%-24.75M

-152.85%-21.42M

-106.98%-14.91M

-16.96%-8.28M

-84.53%-9.02M

-179.94%-8.47M

-68.24%-7.20M

-179.87%-7.08M

-432.93%-4.89M

---3.03M

-709.45%-4.28M

-350.62%-2.53M

-69.19%-917.00K

---529.00K

---561.00K

---542.00K

持續經營利潤

-74.95%-12.69M

-15.53%-12.54M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

51.21%-10.86M

72.96%-13.65M

84.49%-8.30M

49.26%-26.79M

59.39%-22.26M

-20.77%-50.49M

-42.06%-53.52M

-67.76%-52.80M

-109.79%-54.81M

-55.92%-41.80M

-36.39%-37.67M

-19.32%-31.47M

-23.90%-26.13M

-8.31%-26.81M

-28.95%-27.62M

-76.89%-26.38M

-154.82%-21.09M

-174.48%-24.75M

-152.85%-21.42M

-106.98%-14.91M

-16.96%-8.28M

-84.53%-9.02M

-179.94%-8.47M

-68.24%-7.20M

-179.87%-7.08M

-432.93%-4.89M

---3.03M

-709.45%-4.28M

-350.62%-2.53M

-69.19%-917.00K

---529.00K

---561.00K

---542.00K

歸属于母公司的淨利潤

-74.95%-12.69M

-15.53%-12.54M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

51.21%-10.86M

72.96%-13.65M

84.49%-8.30M

49.26%-26.79M

59.39%-22.26M

-20.77%-50.49M

-42.06%-53.52M

-67.76%-52.80M

-109.79%-54.81M

-55.92%-41.80M

-36.39%-37.67M

-19.32%-31.47M

-23.90%-26.13M

-8.31%-26.81M

-28.95%-27.62M

-76.89%-26.38M

-154.82%-21.09M

-174.48%-24.75M

-152.85%-21.42M

-106.98%-14.91M

-16.96%-8.28M

-84.53%-9.02M

-179.94%-8.47M

-68.24%-7.20M

-179.87%-7.08M

-432.93%-4.89M

---3.03M

-709.45%-4.28M

-350.62%-2.53M

-69.19%-917.00K

---529.00K

---561.00K

---542.00K

歸屬普通股東的淨利潤

-74.95%-12.69M

-15.53%-12.54M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

51.21%-10.86M

72.96%-13.65M

84.49%-8.30M

49.26%-26.79M

59.39%-22.26M

-20.77%-50.49M

-42.06%-53.52M

-67.76%-52.80M

-109.79%-54.81M

-55.92%-41.80M

-36.39%-37.67M

-19.32%-31.47M

-23.90%-26.13M

-8.31%-26.81M

-28.95%-27.62M

-76.89%-26.38M

-154.82%-21.09M

-174.48%-24.75M

-152.85%-21.42M

-106.98%-14.91M

-16.96%-8.28M

-84.53%-9.02M

-179.94%-8.47M

-68.24%-7.20M

-179.87%-7.08M

-432.93%-4.89M

---3.03M

-709.45%-4.28M

-350.62%-2.53M

-69.19%-917.00K

---529.00K

---561.00K

---542.00K

基本每股收益

64.12%-0.54

86.60%-0.57

57.74%-2.18

25.84%-2.45

89.19%-1.50

64.59%-4.28

81.33%-5.15

88.76%-3.30

52.96%-13.89

61.28%-12.10

-15.62%-27.60

-36.23%-29.34

-64.03%-29.52

-109.25%-31.24

-55.65%-23.87

-21.64%-21.53

-4.58%-18.00

-7.95%-14.93

10.75%-15.34

-4.83%-17.70

-36.82%-17.21

-88.77%-13.83

-87.58%-17.18

-95.23%-16.89

-70.93%-12.58

-0.98%-7.33

-83.28%-9.16

-179.53%-8.65

-23.05%-7.36

-180.65%-7.26

-432.95%-5.00

---3.09

-569.84%-5.98

-350.59%-2.59

-69.20%-0.94

---0.89

---0.57

---0.55

稀釋每股收益

64.12%-0.54

86.60%-0.57

57.74%-2.18

25.84%-2.45

89.19%-1.50

64.59%-4.28

81.33%-5.15

88.76%-3.30

52.96%-13.89

61.28%-12.10

-15.62%-27.60

-36.23%-29.34

-64.03%-29.52

-109.25%-31.24

-55.65%-23.87

-21.64%-21.53

-4.58%-18.00

-7.95%-14.93

10.75%-15.34

-4.83%-17.70

-36.82%-17.21

-88.77%-13.83

-87.58%-17.18

-95.23%-16.89

-70.93%-12.58

-0.98%-7.33

-83.28%-9.16

-179.53%-8.65

-23.05%-7.36

-180.65%-7.26

-432.95%-5.00

---3.09

-569.84%-5.98

-350.59%-2.59

-69.20%-0.94

---0.89

---0.57

---0.55

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 BioXcel Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 BTAI 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

BioXcel Therapeutics Inc 財年末的營收是多少？



BioXcel Therapeutics Inc 2025 財年營收為 642.00K，高於上一財年的 2.27M。

BioXcel Therapeutics Inc 最近一個季度的營收是多少？



BioXcel Therapeutics Inc 最近一個季度的營收為 206.00K，同比增長 22.62%。

BioXcel Therapeutics Inc 全年的淨利潤是多少？



BioXcel Therapeutics Inc 2025 財年淨利潤為 -69.90M。

BioXcel Therapeutics Inc 上一季度的淨利潤是多少？



BioXcel Therapeutics Inc 最近一個季度的淨利潤為 -12.69M。

BioXcel Therapeutics Inc 年度營業利潤是多少？



BioXcel Therapeutics Inc 2025 財年的營業利潤為 -50.27M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。